Shuffler News
Parkinsons and Dopamine Agonists, a story !
The words of someone who has been to hell and back and still climbing out of it.
“Agonists are like your best friend acting nice, but in the bigger picture they have an alterior motive far more sinister than any benefit that the friendship could ever provide.
For most it works, but my experience was stomach churningly horrendous, with life long repucussions of the highest order, loss of business, reputation, family houses, economic and social supports.
Structured social and medical supports, as well as paitent suitability given patient personailty and lifestyle, are required that extend way beyond what the medical profession currently offers .
These supports need to look for and continually monitor for the hidden signals, behaviour changes, reclusiveness, adverse risk taking, clouded judgement, as the participant can very easily deliberately hide the obvious signs of compulsive behaviour, which may seem trivial to those looking in, but will rock the foundations for the person who sought the benefit, ripping their insides with decay and leaving a shell of a human with nothing left inside.”
There is a moral duty of care that isn’t being acknowledged, and those affected are too proud to publicly admit that they fell prey to the fiery forks of the devil disguised.
This could never happen to me, I won’t be judged by my friends so I’ll keep it to myself”
Stories from Agonist Survivors
Parkinsons: Dopamine Agonists. Dangers !
A Day in the Life of Dr. C’s Parkinson’s Self-management
If a casual observer were to take a snapshot of my life, they would see a gray-haired guy sitting down while his partner scurries about doing house chores and computer work. But looks can be
Nerve Cell Lines Derived From Stem Cells of PPMI Study Donors Created
Fujifilm Cellular Dynamics reported that it has developed, using stem cells from people with Parkinson’s disease, dopaminergic neurons containing two common, disease-associated mutations for use in Parkinson’s research. Stem cell donors were patients involved in
Inflammatory Markers, Sleep Disorder Linked In Parkinson’s
Blood levels of c-reactive protein (CRP) and the lymphocyte-to-monocyte ratio (LMR), two indicators of systemic inflammation, were associated with the presence of rapid eye movement (REM) sleep behavior disorder (RBD) in people with Parkinson’s disease,
Cdk5 Inhibitor Shows Early Potential in Easing Anxiety, Aiding Neurons
Researchers have developed a new suppressor of cyclin-dependent kinase 5 (Cdk5) — an enzyme whose activity is associated with neuropsychiatric and neurodegenerative conditions — that can robustly enter the brain and appears to be more
Young Inventor Honored for App to Detect Disease in Facial Expression
The European Patent Office (EPO) has nominated a 22-year-old woman for its inaugural Young Inventors prize in recognition of her artificial intelligence (AI)-powered app that can detect Parkinson’s disease early through facial expressions and might
Drink Up: The Importance of Preventing Dehydration in Parkinson’s
As a resident of Arizona, in the Valley of the Sun, as the Phoenix metro area is known, I am familiar with how quickly one can become dehydrated. Scorching summertime desert temperatures can spike above
Parkinson’s and Essential Tremor Share ‘Central Origin,’ Study Suggests
Accidental falls and co-existing conditions, or comorbidities, like fatigue, depression, and sleeping problems are frequent in older adults with either Parkinson’s disease or essential tremor syndrome, suggesting “similar central origins” for these two disorders, a study reported. Its data
In Mice, COVID-19 Leaves Nerve Cells Vulnerable to Further Injury
A prior COVID-19 infection in mice increased their susceptibility to nerve cell loss caused by MPTP, a neurotoxin known to cause symptoms of Parkinson’s disease, according to a recent study. The findings suggest that while
AbbVie Files for FDA Approval of ABBV-951 Levodopa Infusion
AbbVie has submitted a new drug application to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa), its investigational under-the-skin formulation of carbidopa/levodopa for the treatment of motor fluctuations in advanced Parkinson’s disease. If
STING Protein Drives Inflammation and Neuronal Loss, Study Finds
A protein called STING, which normally helps sense infectious threats like viruses, may help to drive the inflammation that spurs neurodegeneration in Parkinson’s disease, according to a study in mouse and cell models. The study, “STING
Posts from the author
Shufflernews
Parkinsons
Subscribe
Phone
0490 33 22 68
shuffles@shufflenews.com